Definitive Healthcare (DH) Expected to Announce Earnings on Thursday

Definitive Healthcare (NASDAQ:DH) will likely be issuing its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of $0.06 per share and revenue of $59.5660 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 26, 2026 at 5:00 PM ET.

Definitive Healthcare Trading Up 0.7%

Definitive Healthcare stock opened at $1.39 on Wednesday. The company has a market cap of $196.49 million, a price-to-earnings ratio of -0.83 and a beta of 1.59. The firm has a 50-day moving average of $2.25 and a 200-day moving average of $2.91. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.60 and a quick ratio of 1.60. Definitive Healthcare has a one year low of $1.36 and a one year high of $5.23.

Hedge Funds Weigh In On Definitive Healthcare

A number of institutional investors have recently modified their holdings of the business. BNP Paribas Financial Markets grew its position in Definitive Healthcare by 32.9% in the third quarter. BNP Paribas Financial Markets now owns 17,811 shares of the company’s stock valued at $72,000 after acquiring an additional 4,407 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Definitive Healthcare by 5.8% in the 4th quarter. Invesco Ltd. now owns 117,427 shares of the company’s stock valued at $337,000 after purchasing an additional 6,400 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Definitive Healthcare during the 2nd quarter valued at approximately $32,000. Creative Planning increased its position in Definitive Healthcare by 41.7% during the 2nd quarter. Creative Planning now owns 28,628 shares of the company’s stock worth $112,000 after purchasing an additional 8,428 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC acquired a new stake in Definitive Healthcare in the fourth quarter valued at approximately $35,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on DH shares. Barclays cut their price objective on Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating for the company in a research report on Monday, December 8th. Wall Street Zen cut Definitive Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, December 28th. William Blair raised shares of Definitive Healthcare to a “strong-buy” rating in a research report on Thursday, November 6th. Morgan Stanley reiterated an “underperform” rating and issued a $3.50 price objective on shares of Definitive Healthcare in a report on Thursday, December 18th. Finally, Canaccord Genuity Group cut their target price on shares of Definitive Healthcare from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Monday, November 10th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, three have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $3.94.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.